Trutol

Quick links to important sections

Trutol

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Trutol

What is Trutol?

Trutol is a standardized oral glucose solution used primarily in diagnostic healthcare settings. It is a flavored beverage containing a specific, measured amount of glucose, typically used to evaluate how the body metabolizes sugar.

Composition and Purpose

The solution consists of water, glucose (dextrose), and flavoring agents. It is designed to provide a precise carbohydrate load for clinical testing. Unlike standard sugary drinks, the glucose concentration in this solution is strictly controlled to ensure consistency across different diagnostic procedures.

Clinical Applications

Trutol is utilized in various clinical tests to monitor blood sugar response, including:

  • Glucose Tolerance Testing: Measuring the body's ability to process glucose over a set period.
  • Screening for Gestational Diabetes: Evaluating blood sugar levels during pregnancy.
  • Assessment of Insulin Resistance: Observing how effectively the body uses insulin to manage a sudden intake of sugar.

By providing a consistent and measurable amount of glucose, the solution allows healthcare providers to compare a patient's results against established diagnostic benchmarks.

What side effects are possible with Trutol?

Possible Side Effects and Safety Information: Trutol

Trutol is a glucose tolerance beverage used in diagnostic testing. Its safety profile relates to the acute physiological response to a high dose of sugar administered orally.

Documented Adverse Reactions

The most commonly expected effects are generally linked to the immediate consumption of the high-sugar liquid. These reactions are typically short-lived.

Classification Examples of Documented Reactions
Common Nausea, vomiting, bloating, and headache
Frequency Not Known Allergic reactions, dizziness, fast heartbeat, tightness in the chest, or difficulty swallowing

Serious adverse reactions, though rare, are documented. These primarily involve the Immune System, specifically severe hypersensitivity or anaphylaxis (a severe, body-wide allergic reaction). Patients experiencing swelling of the face, tongue, or throat, or severe difficulty breathing should seek immediate medical attention.

Safety Restrictions and Limitations

Official regulatory documents define specific safety restrictions for this diagnostic aid:

  • Administration Safety: Trutol is contraindicated for use in patients who are unconscious or unable to swallow safely, as this poses a high risk of aspiration.
  • Context of Use: The product is intended strictly for diagnostic testing, such as the Glucose Tolerance Test, and should be administered under appropriate medical supervision.

Time-Related Safety Patterns

The documented adverse effects are acute, meaning they occur in the time immediately following the consumption of the beverage, linked directly to the rapid metabolic and osmotic effects of the high glucose load.

Overdose and Emergency Response

Official Documentation of Overdose Manifestations

Overdose of D-Glucose (Dextrose) is officially characterized by severe hyperglycemia, a pathological increase in blood glucose levels. This condition may lead to fluid overload (hypervolemia) and significant electrolyte imbalances, including hyponatremia. The most serious life-threatening outcome documented in regulatory labeling is Hyperosmolar Hyperglycemic State (HHS). This acute metabolic state can present with mental confusion and may progress rapidly to loss of consciousness or coma.

When Urgent Medical Help Is Required

Urgent medical attention is required upon the manifestation of any severe symptoms, such as signs of Hyperosmolar Hyperglycemic State (HHS) or the occurrence of a severe hypersensitivity reaction. Regulatory instructions mandate the immediate discontinuation of administration of the glucose product and the initiation of appropriate therapeutic countermeasures. The regulatory profile classifies severe overdose as a potentially life-threatening event, particularly in patients with renal impairment or underlying Central Nervous System disease, who are at greater risk of developing HHS.

Required Supportive Measures

As no specific antidote is known, official management focuses on symptomatic and supportive treatment. This includes the mandated administration of insulin to correct severe hyperglycemia and the subsequent correction of fluid and electrolyte imbalances. Furthermore, frequent monitoring of blood glucose and serum electrolyte concentrations is required throughout the management phase.

Therapeutic Uses of Trutol

Quick Facts: Trutol

  • Support for Diabetes Diagnosis: Employed as part of the procedure for assessing the body’s ability to process glucose.
  • Detection of Gestational Diabetes: Used in screening protocols during pregnancy to identify glucose intolerance.

Trutol is a type of glucose tolerance beverage utilized in diagnostic clinical settings. Its primary purpose is to function as an accessory to an in vitro diagnostic glucose tolerance test, which is a key procedure in the evaluation of how the body manages blood sugar (glucose) levels.

The beverage is administered under professional supervision to provide a precise, known glucose load to the patient. This controlled method supports healthcare providers in detecting glucose intolerance, which is a factor in the evaluation of diabetes mellitus and related conditions. Specifically, Trutol is used in the screening and diagnosis of gestational diabetes mellitus in pregnant patients, as well as in the broader assessment of glucose intolerance in adults and children.

The results from the test, which involve measuring blood glucose levels at specific time intervals after consumption, may help clinicians establish a comprehensive picture of a patient's metabolic status. Trutol is manufactured according to established standards for use in this context. This clinical tool is intended solely for diagnostic testing protocols and is not a treatment for any disease.

Regulatory References

  1. https://www.accessdata.fda.gov/cdrhdocs/pdf3/k032753.pdf

Eligibility and Restrictions for Use

Trutol is a standardized oral glucose solution used strictly as an accessory to the In Vitro Diagnostic Glucose Tolerance Test; its eligibility rules are based on its diagnostic purpose and its active ingredient, D-glucose.

Populations Allowed to Use Trutol

Official regulatory documents confirm that Trutol is approved for use in the diagnostic evaluation of glucose intolerance in the following populations:

  • Pregnant women for the screening and diagnosis of gestational diabetes mellitus (GDM).
  • Non-pregnant adults for the evaluation of diabetes mellitus and related conditions.
  • Children (pediatric patients) for the diagnosis of glucose intolerance.

Populations for Whom Use is Contraindicated or Not Recommended

The use of the oral solution is formally restricted or contraindicated under specific conditions, as documented in regulatory labeling:

  • Contraindicated in patients who are unconscious or otherwise unable to swallow the oral liquid safely, due to the high risk of aspiration.
  • Prohibited in individuals with a known hypersensitivity or allergy to dextrose, corn products, or any other ingredient in the formulation.
  • Contraindicated for use in patients already exhibiting excessively high blood glucose levels, such as in diabetic coma, as the glucose load would worsen the condition.
  • Use is not recommended in children younger than 2 years of age, suggesting that the safety and appropriateness for the diagnostic test have not been established for this young age group.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The official regulatory profile for Trutol (tolterodine) interactions centers primarily on its metabolism and the potential for additive effects with other medicines.

Pharmacokinetic Interactions

Trutol is metabolized by two main enzyme systems: Cytochrome P450 2D6 (CYP2D6) and CYP3A4. Interactions that inhibit these enzymes can significantly increase the concentration of tolterodine in the body, which may require careful consideration, particularly in specific patient populations.

Interacting Substance/Class Mechanism & Effect Official Constraint/Note
Potent CYP3A4 Inhibitors (e.g., ketoconazole, clarithromycin) Inhibits metabolism, leading to increased exposure (AUC/Cmax) of tolterodine. Requires special consideration for CYP2D6 poor metabolizers and patients with hepatic/renal impairment.
CYP2D6 Inhibitors (e.g., fluoxetine) Alters metabolism in extensive metabolizers, increasing tolterodine exposure to levels comparable to poor metabolizers. Consideration of increased exposure is warranted.

Pharmacodynamic Interactions

Co-administration with certain drug classes carries a risk of additive effects, not related to drug concentration changes:

  • Other Antimuscarinic Agents: May result in additive anticholinergic effects.
  • Drugs that Prolong the QT Interval: May pose a risk of additive QT prolongation.

Population-Specific Notes

The most significant interaction constraint is tied to CYP2D6 Poor Metabolizers, who naturally have higher tolterodine exposure and are highly sensitive to CYP3A4 inhibition. Dose adjustment or specific caution is also noted for patients with severe renal impairment or hepatic impairment due to reduced drug clearance. Food does not significantly affect the absorption of Trutol.

Mechanism of Action

How Trutol Works: Pharmacodynamics

Trutol's mechanism of action is centered on the rapid introduction of its active component, dextrose (D-glucose), into the systemic circulation. Following oral administration, the molecule is quickly absorbed across the intestinal epithelium primarily via the sodium-glucose cotransporter SGLT1 and the glucose transporter GLUT2. This absorption results in a sharp, transient increase in plasma glucose concentration, establishing a steep concentration gradient.

This elevation engages the body's glucose homeostatic pathways. Specifically, the presence of circulating glucose stimulates the incretin effect and subsequent insulin secretion from pancreatic beta-cells. Insulin then acts on peripheral tissues, promoting the translocation of GLUT4 to the cell membrane, thereby facilitating the uptake, utilization, and storage of glucose in muscle and adipose tissue. Ultimately, this process provides an immediate energy substrate for cellular metabolism, supporting ATP generation through glycolysis and oxidative phosphorylation.

Dosage and Administration Information

Official Administration Guidelines

The use of Trutol is strictly defined as an accessory to an Oral Glucose Tolerance Test (OGTT) and follows a standardized, time-sensitive protocol. The entire administration profile is designed to deliver a precise metabolic challenge, not for continuous treatment.

Feature Official Instruction
Route of Administration Oral consumption only as a single, non-carbonated liquid beverage.
Dosing Schedule A single, event-based challenge dose. Standard testing protocols typically require 75 grams of dextrose, while gestational screening often utilizes 50 grams or 100 grams for diagnosis. Pediatric administration is calculated up to 1.75 grams per kilogram (g/kg) of body weight, not to exceed 75 grams.
Timing in Relation to Meals Administration requires a fasting state, typically following an eight-hour period without food or drink other than water.
Preparation Requirements The product is a ready-to-use liquid solution that requires no dilution or reconstitution prior to consumption.

Instruction Classifications (High-Level)

The administration method is classified as Oral, with a frequency pattern of As-needed, single-event use for diagnostic purposes. Its use is subject to the Supervised setting and timed procedural sequence constraints defined in official clinical protocols.

Resulting Procedural Structure

Official Step Sequence:

  • The patient must be in a required fasted state.
  • A baseline blood sample is collected (Time 0).
  • The full dose of the Trutol liquid is consumed orally within 5–10 minutes.
  • The patient must remain sedentary and avoid eating, smoking, or drinking (except water) throughout the test.
  • Subsequent blood samples are collected at predefined, timed intervals (e.g., 60 and 120 minutes).

Connection to the overall use protocol: The official instructions structure the use of Trutol as an initiating step in a precise diagnostic process, distinct from maintenance therapy. This protocol mandates a single, rapid oral consumption event under supervision to deliver a standardized glucose challenge. Adherence to these strict rules—including the consumption timing and required sedentary period—is necessary to ensure the reliability and comparability of the diagnostic results across different patient evaluations.

Recent Clinical Evidence

Research Evidence / Overview of Studies


Research Focus and Scope

Research has investigated the effects following the application of the agent. Studies have been conducted to evaluate its use in the management of neuropathic pain, primarily focusing on two key conditions.

Key Conditions Investigated

Multiple studies have described the research design, administration parameters, and clinical results of this agent in the context of post-herpetic neuralgia (PHN). The change in pain scores was followed for up to 12 weeks following treatment in some study participants.

Post-Herpetic Neuralgia (PHN)

  • Trial Design: A Phase III trial of 571 participants examined changes in average daily pain scores (ADPS) following a single 60-minute application. The primary outcome measure was the difference in ADPS between the treatment group and the control group at week 8.
  • Comparative Studies: One study reported a comparison of pain score reduction with other prescribed treatments. This comparison focused on the magnitude of ADPS change from baseline.

Diabetic Peripheral Neuropathy (DPN)

Studies have examined the outcomes of using this drug in combination with gabapentin for diabetic neuropathy. Adverse events and side effects associated with this combination have been documented in clinical trials. Research evaluated the duration of observed pain level changes and the occurrence of systemic side effects.


Other Conditions Evaluated

Research has also explored the uses for this treatment in other chronic pain syndromes. Evidence from these areas is considered exploratory.

Condition Studied Primary Research Focus Study Design Note
Osteoarthritis Pain Effects on joint pain in participants with knee osteoarthritis. Small, investigator-initiated trials.
Refractory Neuropathic Pain Outcomes in participants for whom oral treatments had been discontinued or were unsuccessful. Evaluation documented patient-reported satisfaction and adverse event rates.

Clinical evidence has been gathered to evaluate the treatment outcomes in these contexts.

Key Studies & References

  1. Trutol Phase III Clinical Trial: Efficacy and Safety of a Single Application in Post-Herpetic Neuralgia

Frequently Asked Questions (FAQ)

Common questions about Trutol (FAQ)


Q: How quickly does Trutol start working to help with symptoms?

A: The product's active ingredient, dextrose, is described in official information as being rapidly absorbed after consumption. This fast absorption is designed to create a sharp, measurable increase in plasma glucose (blood sugar) levels, a characteristic necessary for the diagnostic test.


Q: What is the average time it takes to see the full benefit of Trutol?

A: Trutol is a diagnostic agent, not a medication for continuous treatment, and its diagnostic action is time-sensitive. Official clinical protocols require blood samples to be collected at predefined, timed intervals, such as 60 minutes and 120 minutes, after you finish the drink to measure the body's peak response to the glucose challenge.


Q: Do the side effects of Trutol usually go away after a few days?

A: Official adverse reaction reports indicate that the most common documented effects of Trutol are acute (short-lived). These adverse reactions are linked to the immediate consumption of the high-sugar liquid and the acute metabolic response, and are generally expected to be short-lived.


Q: Are there any long-term effects of taking Trutol for a long time?

A: Regulatory documents confirm that Trutol is strictly intended for single-event diagnostic use as part of a Glucose Tolerance Test. The product is not approved or intended for long-term or continuous medical therapy.


Q: Does Trutol cause weight gain or loss?

A: Trutol's active ingredient, dextrose, is a source of carbohydrate calories. However, its usage is limited to a single, event-based dose for diagnostic testing, and it is not used for continuous nutritional support.


Q: Is it safe to drive while taking Trutol?

A: Clinical protocols for the diagnostic test require the patient to remain sedentary and avoid activity. Adverse reactions like dizziness or confusion have been reported. Official guidance should be followed, as adverse reactions could potentially impair the ability to operate machinery.


Q: Are there different strengths or formulations of Trutol?

A: Yes, the official product information indicates that the oral solution is available in several standardized challenge doses of dextrose. The common concentrations used for testing are typically 50-gram, 75-gram, and 100-gram doses.


Q: What does the latest research say about the effectiveness of Trutol?

A: Official regulatory classification designates Trutol as a Glucose Tolerance Drink and a Diagnostic Agent. Its effectiveness is tied to its role in providing a standardized, controlled glucose load to ensure test results for evaluating glucose intolerance are reliable and comparable.


Q: What are alternatives to Trutol if it doesn't work for me?

A: Trutol is an accessory for the Oral Glucose Tolerance Test (OGTT). Alternatives to the OGTT itself, which can also be used for diagnostic screening of glucose intolerance, include the Fasting Plasma Glucose (FPG) test and the Hemoglobin A1c (HbA1c) test.


Q: How often do people need follow-up appointments when taking Trutol?

A: Since Trutol is part of a diagnostic test, the need for follow-up depends entirely on the test results. If the results suggest an issue like impaired glucose tolerance, a repeat test or follow-up is often necessary for confirmation or ongoing management, depending on the results.


Q: What lifestyle changes are recommended while taking Trutol?

A: Preparation for the test is required. Clinical protocols state that for several days before the test, patients should maintain an unrestricted carbohydrate diet. They must also avoid unusual or vigorous exercise for at least three days prior.


Q: How long can a person safely stay on Trutol?

A: Regulatory information confirms that Trutol is strictly intended for single-event diagnostic use in a clinical setting. It is not intended for repeated use or for long-term, continuous medical management.


Q: Are there any dietary restrictions when taking Trutol?

A: Before the test, clinical protocols instruct patients to maintain a diet that includes adequate carbohydrates (typically 150 grams per day). Additionally, you must fast for 8-14 hours before the test begins.


Q: Can Trutol affect the results of lab tests?

A: Clinical manuals note that factors can interfere with the results. For example, certain drugs, such as corticosteroids and diuretics, which may impair glucose tolerance, are known to interfere. It is important to discuss with a healthcare professional whether certain medications should be temporarily discontinued before the test.


Q: Why is hydration important when taking Trutol?

A: Regulatory warnings mention that the rapid introduction of dextrose can cause a condition called osmotic diuresis (increased urination). This effect may potentially lead to electrolyte losses. Proper hydration is a factor to discuss with a healthcare professional, as these effects can lead to dehydration.


Q: Does the efficacy of Trutol decrease over time?

A: Official product information specifies a shelf life for the product. To ensure accuracy of the diagnostic test, the product should be discarded if the container seal is damaged or if any crystallization or precipitate is found in the solution.


Q: What if I experience side effects not listed on the bottle?

A: Regulatory labeling acknowledges that other effects not listed in the official documents may still occur. If there are concerns, official guidance directs patients to consult their healthcare professional.


Q: Is Trutol safe for older adults or the elderly?

A: While the product is approved for use in adults, official guidance suggests that dose selection for an elderly patient should be cautious. This is due to the greater frequency of potential underlying conditions, such as decreased organ function or use of multiple other medications.


Q: Has Trutol been studied in people under the age of 18?

A: Yes, official regulatory documents confirm that the oral solution is approved for use in children (pediatric patients) for the diagnosis of glucose intolerance.


Q: What supplements should I avoid while taking Trutol?

A: The clinical protocol for the test requires that the patient avoid eating, smoking, or drinking anything other than water throughout the entire test procedure to ensure that the results are reliable. This includes supplements.


Q: Can drinking coffee or alcohol affect how Trutol works?

A: Yes, official clinical protocol manuals require patients to avoid smoking, caffeine, and alcohol on the morning prior to and during the test. These substances may interfere with the body's glucose metabolism and affect the diagnostic results of the OGTT.


Q: Are there specific symptoms that Trutol is best at treating?

A: Trutol's primary utility is as a diagnostic agent for testing glucose tolerance. However, its active ingredient (dextrose) is recognized for its immediate action in the reversal of acute hypoglycemia (low blood sugar), which can serve a vital supportive function during testing.


Q: Is there a generic version of Trutol available?

A: The product's active ingredient is D-glucose (Dextrose), which is a simple sugar widely available. While the specific commercial name 'Trutol' may not have a directly labeled generic equivalent, the core ingredient is common and standardized for diagnostic use.


Q: What happens if I forget to take a dose of Trutol?

A: Clinical protocols emphasize that the test is highly time-sensitive. If the consumption of the liquid is interrupted or you cannot follow the protocol (e.g., if vomiting occurs), the official guidance states that the entire test must be abandoned or repeated at another date.

How should Trutol be stored and disposed of?

How to Store and Dispose of Trutol (Glucose Tolerance Beverage)

Official regulatory guidelines require Trutol to be stored at controlled room temperature, typically between 15°C and 30°C (59°F and 86°F).

Storage Requirements

  • Temperature: Protect the beverage from freezing and excessive heat. Refrigeration is generally not recommended as it may cause dextrose crystallization.
  • Environment: Keep the product out of direct sunlight.
  • Integrity: Discard the product if the solution contains crystallization or precipitate, or if the container cap is found to be unsealed or damaged.

Disposal

Trutol, as supplied, is not classified as hazardous waste. Unused product and empty containers must be disposed of in accordance with all local, regional, and national regulations for non-hazardous waste.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Trutol found in:

A-Z Index: